← Back to Patent Explorer
US5475052A Expired / Lapsed US ⏱️ 0.0 years remaining

Collagen-synthetic polymer matrices prepared using a multiple step reaction

Assignee: Surgical Specialties US Corp
•
Filing: 1994-05-02
•
Granted: 1995-12-12
•
Expires: 2014-05-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention discloses collagen-synthetic polymer matrices which are prepared using a multiple step reaction. The first step of the reaction generally involves reacting collagen with a functionally activated synthetic hydrophilic polymer to form a collagen-synthetic polymer matrix. The synthetic hydrophilic polymer may be mono- or multifunctionally activated, but is preferably difunctionally activated, resulting in the formation of a crosslinked collagen matrix. The second step comprises modifying the collagen-synthetic polymer matrix according to one or more of the following methods: further crosslinking the matrix using a multifunctionally activated synthetic polymer, conjugating the matrix using a monofunctionally activated synthetic polymer, coupling biologically active molecules or glycosaminoglycans to the matrix, crosslinking the matrix using conventional chemical crosslinking agents, or modifying the collagen in the matrix by means of various chemical reactions. An optional third step may include further modification of the collagen-synthetic polymer matrix by covalently binding, for example, biologically active molecules or glycosaminoglycans to the matrix by means of available active groups on the synthetic hydrophilic polymers. Collagen-synthetic polymer matrices prepared according to the methods of the present invention have very low immunogenicity and can therefore be used to prepare biocompatible implants for use in a variety of medical applications.

Inventors

  • 👤 Woonza M. Rhee
  • 👤 Richard A. Berg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:01
CPC Classifications
G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/59; A61K47/60; A61K47/61; A61L; A61L15/00; A61L15/16; A61L15/22; A61L15/225; A61L24/00; A61L24/04; A61L24/10; A61L24/102; A61L26/00; A61L26/0009; A61L26/0028; A61L26/0033; A61L27/00; A61L27/14; A61L27/18; A61L27/20; A61L27/22; A61L27/24; A61L27/26; A61L27/28; A61L27/34; A61L27/40; A61L27/44; A61L27/50; A61L27/54; A61L29/00; A61L29/04; A61L29/043; A61L29/044; A61L29/045; A61L29/06; A61L29/14; A61L29/16; A61L31/00; A61L31/04; A61L31/041; A61L31/043; A61L31/044; A61L31/08; A61L31/10; A61L31/12; A61L31/125; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/495; C07K14/78; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0069; C08B37/0072; C08H; C08H1/00; C08H1/06; C08L; C08L89/00; C08L89/04; C08L89/06; C09; C09J; C09J189/00; C09J189/04; C09J189/06; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2/07; A61F2002/072; A61F2310/00; A61F2310/00005; A61F2310/00365; A61K38/00; A61L2300/00; A61L2300/20; A61L2300/23; A61L2300/236; A61L2300/25; A61L2300/252; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/41; A61L2300/412; A61L2300/414; A61L2300/42; A61L2300/426; A61L2300/60; A61L2300/602; A61L2300/62; A61L2430/00; A61L2430/16; C08L2666/00; C08L2666/02

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 77 words
A collagen-polyethylene glycol matrix prepared by the process of: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a chemical substance selected from the group consisting of: a second functionally activated polyethylene glycol, a biologically active agent, a glycosaminoglycan and its derivatives, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, an amino acid, a peptide, and combinations thereof.
Claim 2
Dependent Claim 77 words
A collagen-polyethylene glycol matrix prepared by the process of: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a chemical substance selected from the group consisting of: a second functionally activated polyethylene glycol, a biologically active agent, a glycosaminoglycan and its derivatives, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, an amino acid, a peptide, and combinations thereof.
Claim 3
Dependent Claim 12 words
The matrix of claim 1, wherein the collagen is atelopeptide fibrillar collagen.
Claim 4
Dependent Claim 18 words
The matrix of claim 1, wherein the first functionally activated polyethylene glycol is a difunctionally activated polyethylene glycol.
Claim 5
Dependent Claim 39 words
The matrix of claim 1, wherein the collagen and the first functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 6
Dependent Claim 16 words
The matrix of claim 1, wherein the chemical substance is a second functionally activated polyethylene glycol.
Claim 7
Dependent Claim 30 words
The matrix of claim 5, wherein the second functionally activated polyethylene glycol is selected from the group consisting of a difunctionally activated polyethylene glycol and a monofunctionally activated polyethylene glycol.
Claim 8
Dependent Claim 39 words
The matrix of claim 6, wherein the collagen and the second functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 9
Dependent Claim 38 words
A collagen-polyethylene glycol matrix prepared by the process of: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a second functionally activated polyethylene glycol.
Claim 10
Dependent Claim 38 words
A collagen-polyethylene glycol matrix prepared by the process of: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a second functionally activated polyethylene glycol.
Claim 11
Dependent Claim 12 words
The matrix of claim 8, wherein the collagen is atelopeptide fibrillar collagen.
Claim 12
Dependent Claim 18 words
The matrix of claim 8, wherein the first functionally activated polyethylene glycol is a difunctionally activated polyethylene glycol.
Claim 13
Dependent Claim 39 words
The matrix of claim 4, wherein the collagen and the first functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 14
Dependent Claim 30 words
The matrix of claim 11, wherein the second functionally activated polyethylene glycol is selected from the group consisting of a difunctionally activated polyethylene glycol and a monofunctionally activated polyethylene glycol.
Claim 15
Dependent Claim 39 words
The matrix of claim 8, wherein the collagen and the second functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 16
Dependent Claim 77 words
A process for preparing a collagen-polyethylene glycol matrix comprising: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a chemical substance selected from the group consisting of: a second functionally activated polyethylene glycol, a biologically active agent, a glycosaminoglycan and its derivatives, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, an amino acid, a peptide, and combinations thereof.
Claim 17
Dependent Claim 77 words
A process for preparing a collagen-polyethylene glycol matrix comprising: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a chemical substance selected from the group consisting of: a second functionally activated polyethylene glycol, a biologically active agent, a glycosaminoglycan and its derivatives, a chemical crosslinking agent, an esterifying agent, an amidating agent, an acylating agent, an amino acid, a peptide, and combinations thereof.
Claim 18
Dependent Claim 12 words
The process of claim 14, wherein the collagen is atelopeptide fibrillar collagen.
Claim 19
Dependent Claim 18 words
The process of claim 14, wherein the first functionally activated polyethylene glycol is a difunctionally activated polyethylene glycol.
Claim 20
Dependent Claim 39 words
The process of claim 14, wherein the collagen and the first functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 21
Dependent Claim 16 words
The process of claim 14, wherein the chemical substance is a second functionally activated polyethylene glycol.
Claim 22
Dependent Claim 30 words
The process of claim 18, wherein the second functionally activated polyethylene glycol is selected from the group consisting of a difunctionally activated polyethylene glycol and a monofunctionally activated polyethylene glycol.
Claim 23
Dependent Claim 39 words
The process of claim 18, wherein the collagen and the second functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 24
Dependent Claim 38 words
A process for preparing a collagen-polyethylene glycol matrix comprising: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a second functionally activated polyethylene glycol.
Claim 25
Dependent Claim 38 words
A process for preparing a collagen-polyethylene glycol matrix comprising: reacting collagen with a first functionally activated polyethylene glycol to form a collagen-polyethylene glycol matrix; and further reacting the collagen-polyethylene glycol matrix with a second functionally activated polyethylene glycol.
Claim 26
Dependent Claim 12 words
The process of claim 21, wherein the collagen is atelopeptide fibrillar collagen.
Claim 27
Dependent Claim 18 words
The process of claim 21, wherein the first functionally activated polyethylene glycol is a difunctionally activated polyethylene glycol.
Claim 28
Dependent Claim 39 words
The process of claim 21, wherein the collagen and the first functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.
Claim 29
Dependent Claim 30 words
The process of claim 21, wherein the second functionally activated polyethylene glycol is selected from the group consisting of a difunctionally activated polyethylene glycol and a monofunctionally activated polyethylene glycol.
Claim 30
Dependent Claim 39 words
The process of claim 21, wherein the collagen and the second functionally activated polyethylene glycol are covalently bound by means of a linkage selected from the group consisting of an ether linkage, an ester linkage, and a urethane linkage.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-12-11 1999-06-12 1999-12-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-12-11 2003-06-12 2003-12-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-12-11 2007-06-12 2007-12-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag